Safety analysis of concomitant use of rFVIIa and emicizumab in congenital haemophilia A with inhibitors: Experience from the haven clinical programme-MedSci.cn

Safety analysis of concomitant use of rFVIIa and emicizumab in congenital haemophilia A with inhibitors: Experience from the haven clinical programme

Levy, GG; Asikanius, E; Kuebler, P; el Fegoun, SB; Esberg, S; Seremetis, S

HAEMOPHILIA, 2019; 25 (): 31

科室
- - 订阅+
  - 更多科室
工具
服务